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A common allele at the TAGAP gene locus demonstrates a suggestive, but not conclusive association with risk of rheumatoid
arthritis (RA). To fine map the locus, we conducted comprehensive imputation of CEU HapMap single-nucleotide
polymorphisms (SNPs) in a genome-wide association study (GWAS) of 5500 RA cases and 22621 controls (all of
European ancestry). After controlling for population stratification with principal components analysis, the strongest signal of
association was to an imputed SNP, rs212389 (P¼3.9 10
 8, odds ratio¼0.87). This SNP remained highly significant upon
conditioning on the previous RA risk variant (rs394581, P¼2.2 10
 5) or on a SNP previously associated with celiac disease
and type I diabetes (rs1738074, P¼1.7 10
 4). Our study has refined the TAGAP signal of association to a single haplotype in
RA, and in doing so provides conclusive statistical evidence that the TAGAP locus is associated with RA risk. Our study also
underscores the utility of comprehensive imputation in large GWAS data sets to fine map disease risk alleles.
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Introduction
Contemporary genome-wide association studies
(GWASs) test common single-nucleotide polymorphisms
(SNPs) for association with disease risk. The underlying
biological model is that the causal mutation is in linkage
disequilibrium (LD) with tagging SNPs on the genotyp-
ing array.
1 If the causal mutation is also common, then it
likely resides in close proximity to the disease-associated
SNP. To fine map the strongest signal of association, it is
necessary to perform dense genotyping in large patient
collections, followed by stepwise conditional regression
and haplotype analysis.
2 Genome-wide imputation from
a reference panel, such as HapMap, facilitates this
process by providing high-density coverage of common
alleles across a locus of interest.
3
Rheumatoid arthritis (RA) is a common autoimmune
disease of unclear etiology. Family studies estimate that
450% of the variance in disease risk is genetic.
4 To date,
420 risk loci have been identified conclusively at
Po5 10
 8.
5,6 In an initial RA GWAS meta-analysis of
15855 case–control samples, with replication in an
additional 19915 independent samples, we found
strong but not conclusive evidence that a common SNP
near TAGAP is associated with risk of RA (rs394581,
PGWAS¼5.6 10
 4, Poverall¼3.8 10
 7 in all 35770 case–
control samples combined).
7 This GWAS meta-analysis
did not include complete imputation of all CEU HapMap
SNPs, but rather included only 336721 SNPs genotyped
on the Affymetrix 500K platform (Affymetrix, Santa
Clara, CA, USA) passing genotype quality control filters.
In a follow-up GWAS meta-analysis of 5539 autoanti-
body-positive RA cases and 20269 controls, we imputed
2.56 million SNPs from CEU HapMap and found
continued evidence of association at the previous TAGAP
RA risk SNP (rs394581, PGWAS¼7.7 10
 4).
6 However,
we also found suggestive evidence for additional risk
alleles at the TAGAP locus, including an allele associated
with risk of celiac disease and type I diabetes (TID).
8,9
The purpose of the current study is to refine the signal
of association at the TAGAP locus using our second
GWAS meta-analysis with genome-wide imputation.
Our results show that an imputed SNP at the TAGAP
locus provides a much stronger signal of association than
the previously published SNP in RA.
Results and discussion
The initial goals of this study were to use genome-wide
imputation and conditional analysis to determine if any
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www.nature.com/geneof the known RA risk alleles had either (1) a better signal
of association or (2) an independent, second signal of
association in the associated risk locus. We included
those RA risk loci with conclusive (Po5 10
 8) and
highly suggestive (Po10
 6 with independent replication
at Po0.01) association with risk of RA.
Our GWAS meta-analysis was conducted using the six
case–control collections shown in Table 1. Within each
collection, we first filtered SNPs and individuals, and then
ran Eigenstrat
10 on genotyped SNPs to calculate principal
components, as previously described.
6 We used filtered
SNPs to impute 2.56 million SNPs present at 41% allele
frequency in CEU HapMap.
3 GWAS association analyses
were performed using logistic regression (SNPTEST and
R), incorporating the top five principal components as
covariates to control for population stratification. We
combined the results of the GWAS for each data set by
weighting the logistic regression estimates (beta values)
by the inverse variance of each data set.
11 In our final
analysis of 5500 RA cases and 22621 controls (all of
European ancestry) with genotype data at 2.56 million
SNPs, we found no evidence of systemic bias (lGC¼1.01).
In comparison with the published GWAS by Stahl et al.,
6
here we added 2352 additional shared controls because
we incorporated PC’s into the GWAS to correct for
stratification. In doing so, we removed 39 RA cases
because they were determined to be genetic outliers by
PC’s in the expanded data set.
To refine the signal of association at each RA risk locus,
we conditioned on the previously described SNP
genotype to look for additional statistical evidence of
association at other nearby SNPs. For each of the known
RA risk loci, we assessed association statistics, both
before and after conditional analysis, of SNPs within a
1-Megabase (Mb) region centered on the known RA risk
allele. In our analysis conditional on the previously
associated SNP, the TAGAP locus had a clear signal that
was different than the previously reported SNP (Supple-
mentary Table 1). The TNFAIP3, CCL21, CTLA4-CD28
and ANKRD55-IL6ST loci showed evidence of indepen-
dent, second signals of association, consistent with
previous reports.
6,7,12 No other loci showed strong
evidence for association after analysis conditional on
the previously associated RA SNP (conditional Po10
 4).
Because of these findings, we focused solely on refining
the signal of association at the TAGAP locus. We note,
however, that our study design has limited power to
detect independent rare alleles or common alleles of
more modest effect.
In unconditional analysis, the new TAGAP SNP,
rs212389, reached a conservative level of genome-wide
significance in our GWAS meta-analysis (P¼3.9 10
 8,
odds ratio¼0.87). As shown in Figure 1a, the new
TAGAP SNP, rs212389, was five orders of magnitude
more significant than the previously reported TAGAP
SNP (rs394581). These two SNPs are located only 7.3kb
apart and are in LD with one another (r
2¼0.59 and
D0 ¼0.92). Importantly, the new TAGAP SNP had not
been genotyped directly in any of the six collections.
Conditional analysis revealed that the new TAGAP
SNP, rs212389, better explains the association at this
locus than the previously associated RA TAGAP
SNP. After conditioning on the previously reported
TAGAP SNP (rs394581), the new TAGAP SNP
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Genes and ImmunityFigure 1b). In contrast, conditioning on the new TAGAP
SNP abrogated any remaining signal across the entire
1-Mb region, including any signal at the previously
reported TAGAP SNP (rs394581; P¼0.07; Figure 1c).
The same TAGAP locus is associated with risk of celiac
disease and TID.
8,9 The celiac/TID risk allele appears
different than the RA risk allele, as the new RA SNP
demonstrates evidence of association even after analysis
conditioning on the celiac/TID SNP, rs1738074 (P¼
1.7 10
 4). These results are consistent with the patterns
of LD between the pairs of SNPs: the celiac/TID SNP,
rs1738074, has r
2¼0.32 with the new RA risk SNP,
rs212389, and r
2¼0.35 with the previously reported RA
risk SNP, rs394581.
As the new TAGAP SNP was imputed in all six GWAS
collections, we wanted to ensure that the signal of
association was not driven by any one GWAS collection,
and that the association was not an artifact of imputation.
As shown in Figure 2, the new TAGAP SNP (rs212389)
demonstrated a signal of association in all six GWAS
collections. For the new TAGAP SNP, the imputation scores
were higher for those samples genotyped using the
Illumina platform (Illumina, San Diego, CA, USA; Epide-
miological Investigation of Rheumatoid Arthritis (EIRA),
North American Rheumatoid Arthritis Consortium (NAR-
AC) 1 & 2, and Canada; Supplementary Table 2).
To further fine map the signal of association, we used
our GWAS meta-analysis to construct haplotypes gener-
ated by these three SNPs (new RA SNP, previous RA
SNP and celiac/TID SNP). As the imputation scores were
higher for those samples genotyped using the Illumina
platform, we analyzed only on those 3501 RA cases and
10433 controls genotyped on Illumina (see Table 1). As
shown in Figure 3, our haplotype analysis indicated that
the best genetic model is one in which the haplotype
tagged by the G allele of rs212389 (new RA) and the T
allele of rs1738074 (celiac/TID SNP) confers protection
from RA (P¼1.1 10
 6). A similar but more significant
result is obtained when we use all six GWAS collections
in our analysis (P¼1.8 10
 8).
To test whether risk is best explained by the rs212389-
G/rs1738074-T common haplotype, rather than either
allele alone, we performed an analysis in which we
compared three risk models: G allele of rs212389 (new
RA), T allele of rs1738074 (celiac/TID) and rs212389-G/
rs1738074-T common haplotype. Consistent with our
other analyses, we found that the rs212389-G/rs1738074-
T model was significantly better than either model,
which included only a single SNP (P¼0.01; Supplemen-
tary Table 3). Although this analysis suggests that the
causal allele resides on the rs212389-G/rs1738074-T,
additional genotyping in large multi-ethnic sample
Figure 1 TAGAP results from GWAS meta-analysis. (a) Results conditional only on the top five principal components (PCs). (b) Results
conditional on previous RA SNP, rs394581 (in addition to five PCs). (c) Results conditional on new RA SNP, rs212389 (in addition to five PCs).
In each plot, genotyped SNPs (diamonds) and imputed SNPs (circles) are shown across a 500-kb window, where the color of the symbol
indicates LD (as measured by r
2) to the new RA SNP (rs212389). Two genes, TAGAP and RSPH3, map within the recombination hotspots
(shown in blue); three other genes map to the region (EZR, OSTCL/LOC202459 and FNDC1).
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Genes and Immunitycollections will be required to formally identify the best
genetic model at the TAGAP locus.
Under a model in which the causal allele is common
and tagged by the common G-rs212389/T-rs1738074
haplotype, then the causal allele should be catalogued
within the 1000 Genomes Project, as this haplotype is
common (present in B31% of control chromosomes). We
used phased 1000 Genomes data to identify all variants
in high LD (r
240.80) with the new risk haplotype
(Supplementary Table 4). At this LD threshold, we
identified only 10 potential causal variants. However,
none of these variants were within the protein-coding
sequence of TAGAP or other neighboring genes, and
none disrupted an obvious non-coding functional motif
(for example, transcription factor binding site).
Although TAGAP is the most promising biological
candidate gene, four other genes map to the region
of LD: EZR, OSTCL/LOC202459, RSPH3 and FNDC1
(Figure 1). TAGAP gene is expressed at high levels in
the immune system, including B- and T-lymphocyte
cells, dendritic cells, natural killer cells and monocytes.
The protein product is predicted to function as a Rho
GTPase-activating protein. Otherwise, little is known
about the function of TAGAP in the immune system.
There are several important limitations of our study.
First, we did not genotype the new RA-associated SNP in
any samples. The imputation quality score (Supplemen-
tary 2) and the consistency of the effect across the
different cohorts (Figure 2) provide strong evidence that
the signal of association at the imputed SNP is not
because of a technical artifact. Second, no re-sequencing
was done to discover variants not present in either
HapMap or 1000 Genomes data. Formally speaking, our
results could be consistent with a genetic model in which
multiple causal rare variants reside on the common
G-rs212389/T-rs1738074 haplotype, rather than a single
causal allele that resides on this haplotype. Third, our
study is underpowered to detect independent alleles of
modest effect, especially those that are of low allele
frequency (for example, 1–5%). Last, we did not perform
experiments to determine whether the new RA SNP
(rs212389) or any variants from the 1000 Genomes data in
LD with the common G-rs212389/T-rs1738074 haplotype
are functional.
In conclusion, our study provides conclusive evidence
that the TAGAP locus is associated with risk of RA. In
doing so, we have refined the signal of association
at the TAGAP locus either to rs212389 (new RA SNP)
or to a haplotype tagged by the G allele of rs212389
(new RA SNP) and the T allele of rs1738074 (celiac/TID
SNP). Comprehensive imputation was essential to
refine this association, as the new SNP was not
genotyped directly on either the Affymetrix or Illumina
platforms.
Figure 2 TAGAP results for previous RA SNP (rs394581), new RA SNP (rs212389) and celiac/TID SNP (rs1738074), within each GWAS
collection. In each plot, the point estimate of the odds ratio (OR) is shown, with 95% confidence intervals (CI). Genotyped SNPs are indicated
by diamonds and imputed SNPs by circles. The meta-analysis of all six collections is indicated by the filled diamond at the bottom of the
graph, where the edges of the diamond indicate the 95% CI. For the new RA SNP (rs212389), the OR is 0.87 (95% CI 0.83–0.91).
Figure 3 TAGAP results for haplotypes created by the celiac/TID
SNP (rs1738074), previous RA SNP (rs394581) and new RA SNP
(rs212389). Seven haplotypes are created by the three SNPs. The
frequency of each haplotype from the control population is shown.
The point estimate of the odds ratio (OR) and 95% confidence
intervals (CI) are shown.
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